Cargando…

An individualized prognostic signature and multi-omics distinction for early stage hepatocellular carcinoma patients with surgical resection

Previously reported prognostic signatures for predicting the prognoses of postsurgical hepatocellular carcinoma (HCC) patients are commonly based on predefined risk scores, which are hardly applicable to samples measured by different laboratories. To solve this problem, using gene expression profile...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ao, Lu, Song, Xuekun, Li, Xiangyu, Tong, Mengsha, Guo, You, Li, Jing, Li, Hongdong, Cai, Hao, Li, Mengyao, Guan, Qingzhou, Yan, Haidan, Guo, Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029687/ https://www.ncbi.nlm.nih.gov/pubmed/27006471 http://dx.doi.org/10.18632/oncotarget.8212

Ejemplares similares

An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups
por: Li, Xiangyu, et al.
Publicado: (2016)

Differential expression analysis for individual cancer samples based on robust within-sample relative gene expression orderings across multiple profiling platforms
por: Guan, Qingzhou, et al.
Publicado: (2016)

Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer
por: Cai, Hao, et al.
Publicado: (2015)

Identification of reproducible drug-resistance-related dysregulated genes in small-scale cancer cell line experiments
por: Ao, Lu, et al.
Publicado: (2015)

Identifying clinically relevant drug resistance genes in drug-induced resistant cancer cell lines and post- chemotherapy tissues
por: Tong, Mengsha, et al.
Publicado: (2015)

Identifying Reproducible Molecular Biomarkers for Gastric Cancer Metastasis with the Aid of Recurrence Information
por: Li, Mengyao, et al.
Publicado: (2016)

Circumvent the uncertainty in the applications of transcriptional signatures to tumor tissues sampled from different tumor sites
por: Cheng, Jun, et al.
Publicado: (2017)

Individualized analysis reveals CpG sites with methylation aberrations in almost all lung adenocarcinoma tissues
por: Yan, Haidan, et al.
Publicado: (2017)

A Qualitative Transcriptional Signature for Predicting Recurrence Risk of Stage I–III Bladder Cancer Patients After Surgical Resection
por: Li, Yawei, et al.
Publicado: (2019)

A qualitative transcriptional signature for the early diagnosis of colorectal cancer
por: Guan, Qingzhou, et al.
Publicado: (2019)

Discriminating cancer-related and cancer-unrelated chemoradiation-response genes for locally advanced rectal cancers
por: Guo, You, et al.
Publicado: (2016)

A qualitative signature for early diagnosis of hepatocellular carcinoma based on relative expression orderings
por: Ao, Lu, et al.
Publicado: (2018)

Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy
por: Tong, M, et al.
Publicado: (2016)

Common DNA methylation alterations of Alzheimer's disease and aging in peripheral whole blood
por: Li, Hongdong, et al.
Publicado: (2016)

Qualitative transcriptional signature for predicting pathological response of colorectal cancer to FOLFOX therapy
por: He, Jun, et al.
Publicado: (2019)

Identification of Tamoxifen-Resistant Breast Cancer Cell Lines and Drug Response Signature
por: Guan, Qingzhou, et al.
Publicado: (2020)

Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis
por: Yan, Haidan, et al.
Publicado: (2017)

Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer
por: Guan, Qingzhou, et al.
Publicado: (2018)

A Qualitative Transcriptional Signature for the Risk Assessment of Precancerous Colorectal Lesions
por: Guan, Qingzhou, et al.
Publicado: (2021)

Robust transcriptional signatures for low-input RNA samples based on relative expression orderings
por: Liu, Huaping, et al.
Publicado: (2017)

Identification and characterization of genes with absolute mRNA abundances changes in tumor cells with varied transcriptome sizes
por: Cai, Hao, et al.
Publicado: (2019)

A robust qualitative transcriptional signature for the correct pathological diagnosis of gastric cancer
por: Yan, Haidan, et al.
Publicado: (2019)

Identifying disease-associated pathways in one-phenotype data based on reversal gene expression orderings
por: Hong, Guini, et al.
Publicado: (2017)

Biased Influences of Low Tumor Purity on Mutation Detection in Cancer
por: Cheng, Jun, et al.
Publicado: (2020)

Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma
por: Huang, Ziqi, et al.
Publicado: (2021)

Shared liver-like transcriptional characteristics in liver metastases and corresponding primary colorectal tumors
por: Cheng, Jun, et al.
Publicado: (2018)

Statistically controlled identification of differentially expressed genes in one-to-one cell line comparisons of the CMAP database for drug repositioning
por: He, Jun, et al.
Publicado: (2017)

A rank-based algorithm of differential expression analysis for small cell line data with statistical control
por: Li, Xiangyu, et al.
Publicado: (2017)

Robust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples
por: Chen, Rou, et al.
Publicado: (2016)

The Effects of Age, Cigarette Smoking, Sex, and Race on the Qualitative Characteristics of Lung Transcriptome
por: Guan, Qingzhou, et al.
Publicado: (2020)

Identification of Genes Universally Differentially Expressed in Gastric Cancer
por: Shi, Yidan, et al.
Publicado: (2021)

Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data
por: Xu, Yanjun, et al.
Publicado: (2019)

A Qualitative Transcriptional Signature for Predicting Extreme Resistance of ER-Negative Breast Cancer to Paclitaxel, Doxorubicin, and Cyclophosphamide Neoadjuvant Chemotherapy
por: Chen, Yanhua, et al.
Publicado: (2020)

Identifying differentially expressed genes from cross-site integrated data based on relative expression orderings
por: Cai, Hao, et al.
Publicado: (2018)

Multi-Omics Analyses Identify Signatures in Patients with Liver Cirrhosis and Hepatocellular Carcinoma
por: Lai, Ming-Wei, et al.
Publicado: (2022)

Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures
por: Kan, Zhengyan, et al.
Publicado: (2018)

A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma
por: Yang, Jinhuan, et al.
Publicado: (2023)

Multi-level reproducibility of signature hubs in human interactome for breast cancer metastasis
por: Yao, Chen, et al.
Publicado: (2010)

Metabolism-related signatures is correlated with poor prognosis and immune infiltration in hepatocellular carcinoma via multi-omics analysis and basic experiments
por: Shen, Jiapei, et al.
Publicado: (2023)

Multi-omics analyses based on genes associated with oxidative stress and phospholipid metabolism revealed the intrinsic molecular characteristics of pancreatic cancer
por: Wang, Hongdong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0d98s3cmo3af40uh4m9hjm3fiu